The hippo pathway provides novel insights into lung cancer and mesothelioma treatment.
Xiao-Lan LiuRui ZuoWen-Bin OuPublished in: Journal of cancer research and clinical oncology (2018)
The hippo signaling transduction pathway has been demonstrated to play crucial roles in lung cancer and mesothelioma pathogenesis, including tumor development and multidrug resistance, and is emerging as a promising therapeutic target, potentially providing new tools for the detection of these tumors at an early stage.